This chart shows the pharmaceutical companies with the most elixir dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most elixir dosed drugs…
The post Which pharmaceutical companies have the most elixir…
Which pharmaceutical companies have the most elixir dosed drugs? Read Post »
BYDUREON PEN (exenatide synthetic) Astrazeneca ab Patent: 9,198,925 Expiration: Oct 4, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations …
Drug Patent Expirations for the Week of October 4, 2020 Read Post »
Annual Drug Patent Expirations for XIGDUO+XR Xigduo Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are eight…
The post New patent expiration for Astrazeneca Ab drug XIGDUO XR appeared first …
New patent expiration for Astrazeneca Ab drug XIGDUO XR Read Post »
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from three suppliers. There are eighteen patents…
The post New patent expiration for Astrazeneca Ab drug FARXIGA appeare…
New patent expiration for Astrazeneca Ab drug FARXIGA Read Post »
Annual Drug Patent Expirations for QTERN Qtern is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twelve patents…
The post New patent expiration for Astrazeneca Ab drug QTERN appeared first on…
New patent expiration for Astrazeneca Ab drug QTERN Read Post »
BYDUREON (exenatide synthetic) Astrazeneca ab Patent: 9,198,925 Expiration: Oct 4, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dr…
Drug Patent Expirations for the Week of October 4, 2020 Read Post »
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…
The post New patent expiration for Astrazeneca Ab drug BYDUREON appeared…
New patent expiration for Astrazeneca Ab drug BYDUREON Read Post »
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…
The post New patent expiration for Astrazeneca Ab drug BYDUREON PEN …
New patent expiration for Astrazeneca Ab drug BYDUREON PEN Read Post »
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-one…
The post New patent expiration for Astrazeneca Ab drug BYDUREON B…
New patent expiration for Astrazeneca Ab drug BYDUREON BCISE Read Post »
Annual Drug Patent Expirations for QTERNMET+XR Qternmet Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Astrazeneca Ab drug QTERNMET XR appeared fi…
New patent expiration for Astrazeneca Ab drug QTERNMET XR Read Post »